FDA Inspection 1093308 — Organon Pharma (UK) Ltd.

Organon Pharma (UK) Ltd. — FEI 3002807653

The FDA completed an inspection of Organon Pharma (UK) Ltd. on Jun 14, 2018 in Cramlington. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cramlington (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.